Morphine Sulfate Patent Expiration
Morphine Sulfate was first introduced by Hikma Pharmaceuticals Usa Inc
Morphine Sulfate Patents
Given below is the list of patents protecting Morphine Sulfate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Morphine Sulfate | US9072781 | Morphine formulations | Mar 12, 2034 | Fresenius Kabi Usa |
| Morphine Sulfate | US9192608 | Morphine formulations | Mar 12, 2034 | Fresenius Kabi Usa |
| Morphine Sulfate | US9248229 | Packaging system for oxygen-sensitive drugs | Mar 12, 2034 | Fresenius Kabi Usa |
| Arymo Er | US9044402 | Abuse-deterrent pharmaceutical compositions for controlled release | Jul 01, 2033 | Zyla |
| Arymo Er | US9549899 | Abuse deterrent pharmaceutical compositions for controlled release | Jul 01, 2033 | Zyla |
| Morphabond Er | US10314788 | Pharmaceutical compositions configured to deter dosage form splitting | Aug 12, 2028 | Ohemo Life |
| Morphabond Er | US7955619 | Abuse resistant drugs, method of use and method of making | Aug 12, 2028 | Ohemo Life |
| Avinza | US6066339 | Oral morphine multiparticulate formulation |
Nov 25, 2017
(Expired) | King Pharms Llc |
| Depodur | US5891467 | Method for utilizing neutral lipids to modify in vivo release from multivesicular liposomes |
Jan 31, 2017
(Expired) | Pacira Pharms Inc |
| Depodur | US5962016 | Multivesicular liposomes utilizing neutral lipids to modify in vivo release |
Jan 31, 2017
(Expired) | Pacira Pharms Inc |
| Depodur | US6171613 | Method for producing liposomes with increased percent of compound encapsulated |
Oct 01, 2016
(Expired) | Pacira Pharms Inc |
| Depodur | US5997899 | Method for producing liposomes with increased percent of compound encapsulated |
Sep 01, 2016
(Expired) | Pacira Pharms Inc |
| Depodur | US6193998 | Method for producing liposomes with increased percent of compound encapsulated |
Sep 01, 2016
(Expired) | Pacira Pharms Inc |
| Depodur | US6241999 | Method for producing liposomes with increased percent of compound encapsulated |
Sep 01, 2016
(Expired) | Pacira Pharms Inc |
| Depodur | US5807572 | Multivesicular liposomes having a biologically active substance encapsulated therein in the presence of a hydrochloride |
Sep 15, 2015
(Expired) | Pacira Pharms Inc |
| Depodur | US5931809 | Epidural administration of therapeutic compounds with sustained rate of release |
Jul 14, 2015
(Expired) | Pacira Pharms Inc |
| Depodur | US5723147 | Multivesicular liposomes having a biologically active substance encapsulated therein in the presence of a hydrochloride |
Mar 03, 2015
(Expired) | Pacira Pharms Inc |
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Morphine Sulfate's patents.
Latest Legal Activities on Morphine Sulfate's Patents
Given below is the list recent legal activities going on the following patents of Morphine Sulfate.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 8th Year, Large Entity | 02 Aug, 2023 | US9248229 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 24 May, 2023 | US9192608 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 09 Jan, 2023 | US9072781 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 02 Aug, 2019 | US9248229 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 24 May, 2019 | US9192608 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 07 Jan, 2019 | US9072781 |
| Email Notification Critical | 12 Sep, 2016 | US9192608 |
| Filing Receipt - Corrected | 12 Sep, 2016 | US9072781 |
| Change in Power of Attorney (May Include Associate POA) Critical | 12 Sep, 2016 | US9192608 |
| Change in Power of Attorney (May Include Associate POA) Critical | 12 Sep, 2016 | US9072781 |
Morphine Sulfate's Family Patents
Explore Our Curated Drug Screens
Morphine Sulfate Generic API Manufacturers
Several generic applications have been filed for Morphine Sulfate. The first generic version for Morphine Sulfate was by Fresenius Kabi Usa Llc and was approved on Oct 7, 1986. And the latest generic version is by Pharmaceutical Associates Inc and was approved on Sep 12, 2023.
Given below is the list of companies who have filed for Morphine Sulfate generic, along with the locations of their manufacturing plants worldwide.
1. ACTAVIS ELIZABETH
Actavis Elizabeth Llc An Indirect Wholly Owned Sub Of Teva Pharmaceuticals Usa Inc has filed for 9 different strengths of generic version for Morphine Sulfate. Given below are the details of the strengths of this generic introduced by Actavis Elizabeth.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 30MG | tablet, extended release | Prescription | ORAL | AB | Apr 6, 2015 |
| 120MG
(reference standard) | capsule, extended release | Prescription | ORAL | N/A | Jan 16, 2013 |
| 90MG | capsule, extended release | Prescription | ORAL | N/A | Jan 16, 2013 |
| 75MG | capsule, extended release | Prescription | ORAL | N/A | Jan 16, 2013 |
| 60MG | tablet, extended release | Prescription | ORAL | AB | Apr 6, 2015 |
| 45MG | capsule, extended release | Prescription | ORAL | N/A | Jan 16, 2013 |
| 15MG | tablet, extended release | Prescription | ORAL | AB | Apr 6, 2015 |
| 200MG | tablet, extended release | Prescription | ORAL | AB | Apr 6, 2015 |
| 100MG | tablet, extended release | Prescription | ORAL | AB | Apr 6, 2015 |
Manufacturing Plant Locations New
Actavis Elizabeth's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Actavis Elizabeth as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| United States |
| |||
2. ALKEM LABS LTD
Alkem Laboratories Ltd has filed for 2 different strengths of generic version for Morphine Sulfate. Given below are the details of the strengths of this generic introduced by Alkem Labs Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 15MG | tablet | Prescription | ORAL | AB | Dec 3, 2020 |
| 30MG | tablet | Prescription | ORAL | AB | Dec 3, 2020 |
3. ANI PHARMS
Ani Pharmaceuticals Inc has filed for 3 different strengths of generic version for Morphine Sulfate. Given below are the details of the strengths of this generic introduced by Ani Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 100MG/5ML | solution | Discontinued | ORAL | N/A | Apr 17, 2018 |
| 20MG/5ML | solution | Discontinued | ORAL | N/A | Apr 17, 2018 |
| 10MG/5ML | solution | Discontinued | ORAL | N/A | Apr 17, 2018 |
4. CHARTWELL MOLECULAR
Chartwell Molecular Holdings Llc has filed for 2 different strengths of generic version for Morphine Sulfate. Given below are the details of the strengths of this generic introduced by Chartwell Molecular.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 20MG/5ML | solution | Discontinued | ORAL | N/A | Oct 30, 2015 |
| 10MG/5ML | solution | Discontinued | ORAL | N/A | Nov 25, 2015 |
5. DAVA PHARMS INC
Dava Pharmaceuticals Inc has filed for 1 generic for Morphine Sulfate. Given below are the details of the strengths of this generic introduced by Dava Pharms Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 15MG | tablet, extended release | Prescription | ORAL | AB | Jan 28, 2000 |
6. DR REDDYS LABS SA
Dr Reddys Laboratories Sa has filed for 4 different strengths of generic version for Morphine Sulfate. Given below are the details of the strengths of this generic introduced by Dr Reddys Labs Sa.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 30MG | tablet | Discontinued | ORAL | N/A | Jan 12, 2022 |
| 15MG | tablet | Discontinued | ORAL | N/A | Jan 12, 2022 |
| 60MG | tablet, extended release | Discontinued | ORAL | N/A | Oct 28, 2016 |
| 100MG | tablet, extended release | Discontinued | ORAL | N/A | Oct 28, 2016 |
7. EPIC PHARMA LLC
Epic Pharma Llc has filed for 5 different strengths of generic version for Morphine Sulfate. Given below are the details of the strengths of this generic introduced by Epic Pharma Llc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 100MG | tablet, extended release | Discontinued | ORAL | N/A | Jun 23, 2016 |
| 15MG | tablet, extended release | Discontinued | ORAL | N/A | Jun 23, 2016 |
| 30MG | tablet, extended release | Discontinued | ORAL | N/A | Jun 23, 2016 |
| 60MG | tablet, extended release | Discontinued | ORAL | N/A | Jun 23, 2016 |
| 200MG | tablet, extended release | Discontinued | ORAL | N/A | Jun 23, 2016 |
8. FRESENIUS KABI USA
Fresenius Kabi Usa Llc has filed for 2 different strengths of generic version for Morphine Sulfate. All of these versions come by the name ASTRAMORPH PF. Given below are the details of the strengths of this generic introduced by Fresenius Kabi Usa.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.5MG/ML | injectable | Discontinued | INJECTION | N/A | Oct 7, 1986 |
| 1MG/ML | injectable | Discontinued | INJECTION | N/A | Oct 7, 1986 |
Manufacturing Plant Locations New
Fresenius Kabi Usa's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Fresenius Kabi Usa as present at those locations.
| Country | City | Firm Name | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||||||||
9. HIKMA
Hikma Pharmaceuticals Usa Inc has filed for 6 different strengths of generic version for Morphine Sulfate. Given below are the details of the strengths of this generic introduced by Hikma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 4MG/ML | injectable | Prescription | INJECTION | AP | Jan 12, 2023 |
| 8MG/ML | injectable | Prescription | INJECTION | AP | Jan 12, 2023 |
| 10MG/ML | injectable | Prescription | INJECTION | AP | Jan 12, 2023 |
| 100MG/5ML | solution | Discontinued | ORAL | N/A | Jul 6, 2017 |
| 2MG/ML | injectable | Prescription | INJECTION | AP | Jan 12, 2023 |
| 15MG/ML | injectable | Prescription | INJECTION | N/A | Jan 12, 2023 |
Manufacturing Plant Locations New
Hikma's manufacturing plants are situated in 3 countries - United States, Portugal, Jordan. Given below are the details of these plant locations as well as the firm names of Hikma as present at those locations.
| Country | City | Firm Name | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||
| Portugal |
| |||||||||
| Jordan |
| |||||||||
10. HOSPIRA
Hospira Inc has filed for 2 different strengths of generic version for Morphine Sulfate. Given below are the details of the strengths of this generic introduced by Hospira.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1MG/ML | injectable | Prescription | INJECTION | AP | Sep 30, 1992 |
| 0.5MG/ML | injectable | Prescription | INJECTION | AP | Sep 30, 1992 |
Manufacturing Plant Locations New
Hospira's manufacturing plants are situated in 3 countries - Australia, United States, Dominican Republic (the). Given below are the details of these plant locations as well as the firm names of Hospira as present at those locations.
| Country | City | Firm Name | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Australia |
| |||||||||||||
| United States |
| |||||||||||||
| Dominican Republic (the) |
| |||||||||||||
11. IMPAX LABS INC
Impax Laboratories Inc has filed for 7 different strengths of generic version for Morphine Sulfate. Given below are the details of the strengths of this generic introduced by Impax Labs Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 100MG | capsule, extended release | Discontinued | ORAL | N/A | Apr 12, 2016 |
| 60MG | capsule, extended release | Discontinued | ORAL | N/A | Apr 12, 2016 |
| 50MG | capsule, extended release | Discontinued | ORAL | N/A | Apr 12, 2016 |
| 30MG | capsule, extended release | Discontinued | ORAL | N/A | Apr 12, 2016 |
| 20MG | capsule, extended release | Discontinued | ORAL | N/A | Apr 12, 2016 |
| 80MG | capsule, extended release | Discontinued | ORAL | N/A | Apr 12, 2016 |
| 40MG | capsule, extended release | Discontinued | ORAL | N/A | Jul 25, 2018 |
12. INGENUS PHARMS NJ
Ingenus Pharmaceuticals Nj Llc has filed for 2 different strengths of generic version for Morphine Sulfate. Given below are the details of the strengths of this generic introduced by Ingenus Pharms Nj.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 30MG | tablet | Discontinued | ORAL | N/A | Feb 7, 2022 |
| 15MG | tablet | Discontinued | ORAL | N/A | Feb 7, 2022 |
13. INTL MEDICATION SYS
International Medication Systems Ltd has filed for 1 generic for Morphine Sulfate. Given below are the details of the strengths of this generic introduced by Intl Medication Sys.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1MG/ML | injectable | Prescription | INJECTION | N/A | Apr 29, 2021 |
14. NESHER PHARMS
Nesher Pharmaceuticals Usa Llc has filed for 5 different strengths of generic version for Morphine Sulfate. Given below are the details of the strengths of this generic introduced by Nesher Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 60MG | tablet, extended release | Discontinued | ORAL | N/A | May 19, 2004 |
| 15MG | tablet, extended release | Discontinued | ORAL | N/A | May 19, 2004 |
| 30MG | tablet, extended release | Discontinued | ORAL | N/A | Dec 23, 2005 |
| 100MG | tablet, extended release | Discontinued | ORAL | N/A | Sep 27, 2007 |
| 200MG | tablet, extended release | Discontinued | ORAL | N/A | Sep 27, 2007 |
15. NORTEC DEV ASSOC
Nortec Development Assoc Inc has filed for 6 different strengths of generic version for Morphine Sulfate. Given below are the details of the strengths of this generic introduced by Nortec Dev Assoc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 50MG | capsule, extended release | Discontinued | ORAL | N/A | Aug 4, 2021 |
| 30MG | capsule, extended release | Discontinued | ORAL | N/A | Aug 4, 2021 |
| 20MG | capsule, extended release | Discontinued | ORAL | N/A | Aug 4, 2021 |
| 60MG | capsule, extended release | Discontinued | ORAL | N/A | Aug 4, 2021 |
| 80MG | capsule, extended release | Discontinued | ORAL | N/A | Aug 4, 2021 |
| 100MG | capsule, extended release | Discontinued | ORAL | N/A | Aug 4, 2021 |
16. NOSTRUM LABS INC
Nostrum Laboratories Inc has filed for 1 generic for Morphine Sulfate. Given below are the details of the strengths of this generic introduced by Nostrum Labs Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 100MG/5ML | solution | Prescription | ORAL | AA | Oct 6, 2016 |
17. NOVEL LABS INC
Novel Laboratories Inc has filed for 5 different strengths of generic version for Morphine Sulfate. Given below are the details of the strengths of this generic introduced by Novel Labs Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 100MG | tablet, extended release | Discontinued | ORAL | N/A | Dec 16, 2015 |
| 30MG | tablet, extended release | Discontinued | ORAL | N/A | Dec 16, 2015 |
| 200MG | tablet, extended release | Discontinued | ORAL | N/A | Dec 16, 2015 |
| 15MG | tablet, extended release | Discontinued | ORAL | N/A | Dec 16, 2015 |
| 60MG | tablet, extended release | Discontinued | ORAL | N/A | Dec 16, 2015 |
18. PADAGIS US
Padagis Us Llc has filed for 1 generic for Morphine Sulfate. Given below are the details of the strengths of this generic introduced by Padagis Us.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 100MG/5ML | solution | Prescription | ORAL | AA | Aug 6, 2012 |
Manufacturing Plant Locations New
Padagis Us's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Padagis Us as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| United States |
| |||
19. PHARM ASSOC
Pharmaceutical Associates Inc has filed for 2 different strengths of generic version for Morphine Sulfate. Given below are the details of the strengths of this generic introduced by Pharm Assoc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 100MG/5ML | solution | Discontinued | ORAL | N/A | Nov 14, 2016 |
| 10MG/5ML | solution | Discontinued | ORAL | N/A | Sep 12, 2023 |
20. PIRAMAL CRITICAL
Piramal Critical Care Inc has filed for 2 different strengths of generic version for Morphine Sulfate. All of these versions come by the name MITIGO. Given below are the details of the strengths of this generic introduced by Piramal Critical.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 10MG/ML | injectable | Prescription | INJECTION | AP | Jul 16, 2018 |
| 25MG/ML | injectable | Prescription | INJECTION | AP | Jul 16, 2018 |
Manufacturing Plant Locations New
Piramal Critical's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Piramal Critical as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| United States |
| |||
21. RHODES PHARMS
Rhodes Pharmaceuticals Lp has filed for 8 different strengths of generic version for Morphine Sulfate. Given below are the details of the strengths of this generic introduced by Rhodes Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 200MG | tablet, extended release | Prescription | ORAL | AB | Jul 2, 1998 |
| 100MG | tablet, extended release | Prescription | ORAL | AB | Jul 2, 1998 |
| 60MG | tablet, extended release | Prescription | ORAL | AB | Jul 7, 1998 |
| 30MG | tablet, extended release | Prescription | ORAL | AB | Jul 7, 1998 |
| 15MG | tablet, extended release | Prescription | ORAL | AB | Jul 7, 1998 |
| 20MG/5ML | solution | Discontinued | ORAL | N/A | Jul 12, 2016 |
| 100MG/5ML | solution | Discontinued | ORAL | N/A | Jun 22, 2017 |
| 10MG/5ML | solution | Discontinued | ORAL | N/A | Jun 22, 2017 |
22. RISING
Rising Pharma Holdings Inc has filed for 5 different strengths of generic version for Morphine Sulfate. Given below are the details of the strengths of this generic introduced by Rising.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 30MG | tablet, extended release | Discontinued | ORAL | N/A | Oct 18, 2011 |
| 100MG | tablet, extended release | Discontinued | ORAL | N/A | Oct 18, 2011 |
| 200MG | tablet, extended release | Discontinued | ORAL | N/A | Oct 18, 2011 |
| 15MG | tablet, extended release | Discontinued | ORAL | N/A | Oct 18, 2011 |
| 60MG | tablet, extended release | Discontinued | ORAL | N/A | Oct 18, 2011 |
Manufacturing Plant Locations New
Rising's manufacturing plants are situated in 3 countries - United States, Mexico, India. Given below are the details of these plant locations as well as the firm names of Rising as present at those locations.
| Country | City | Firm Name | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||||||||||
| Mexico |
| |||||||||||||||||||
| India |
| |||||||||||||||||||
23. SANKALP LIFECARE
Sankalp Lifecare Inc has filed for 3 different strengths of generic version for Morphine Sulfate. Given below are the details of the strengths of this generic introduced by Sankalp Lifecare.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 10MG/5ML | solution | Discontinued | ORAL | N/A | Feb 5, 2014 |
| 20MG/5ML | solution | Discontinued | ORAL | N/A | Feb 5, 2014 |
| 100MG/5ML | solution | Discontinued | ORAL | N/A | Oct 6, 2016 |
24. SPECGX LLC
Specgx Llc has filed for 6 different strengths of generic version for Morphine Sulfate. Given below are the details of the strengths of this generic introduced by Specgx Llc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 100MG | tablet, extended release | Prescription | ORAL | AB | Jul 3, 2003 |
| 200MG | tablet, extended release | Prescription | ORAL | AB | Jul 3, 2003 |
| 15MG | tablet | Prescription | ORAL | AB | Aug 21, 2023 |
| 30MG | tablet | Prescription | ORAL | AB | Aug 21, 2023 |
| 60MG | tablet, extended release | Prescription | ORAL | AB | Jul 31, 2003 |
| 100MG/5ML | solution | Prescription | ORAL | AA | Jul 15, 2011 |
Manufacturing Plant Locations New
Specgx Llc's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Specgx Llc as present at those locations.
| Country | City | Firm Name | ||||||
|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||
25. STRIDES PHARMA
Strides Pharma Global Pte Ltd has filed for 8 different strengths of generic version for Morphine Sulfate. Given below are the details of the strengths of this generic introduced by Strides Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 30MG | capsule, extended release | Discontinued | ORAL | N/A | Nov 10, 2011 |
| 15MG | tablet, extended release | Prescription | ORAL | AB | Oct 28, 1998 |
| 60MG | capsule, extended release | Discontinued | ORAL | N/A | Nov 10, 2011 |
| 100MG | capsule, extended release | Discontinued | ORAL | N/A | Nov 10, 2011 |
| 200MG | tablet, extended release | Prescription | ORAL | AB | Sep 15, 2000 |
| 80MG | capsule, extended release | Discontinued | ORAL | N/A | Nov 10, 2011 |
| 20MG | capsule, extended release | Discontinued | ORAL | N/A | Nov 10, 2011 |
| 50MG | capsule, extended release | Discontinued | ORAL | N/A | Nov 10, 2011 |
Manufacturing Plant Locations New
Strides Pharma's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Strides Pharma as present at those locations.
| Country | City | Firm Name | ||||
|---|---|---|---|---|---|---|
| United States |
| |||||
| India |
| |||||
26. SUN PHARM INDS LTD
Sun Pharmaceutical Industries Ltd has filed for 5 different strengths of generic version for Morphine Sulfate. Given below are the details of the strengths of this generic introduced by Sun Pharm Inds Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 100MG | tablet, extended release | Prescription | ORAL | AB | May 11, 2012 |
| 15MG | tablet, extended release | Prescription | ORAL | AB | May 11, 2012 |
| 30MG | tablet, extended release | Prescription | ORAL | AB | May 11, 2012 |
| 60MG | tablet, extended release | Prescription | ORAL | AB | May 11, 2012 |
| 200MG | tablet, extended release | Prescription | ORAL | AB | May 11, 2012 |
27. SUN PHARM INDUSTRIES
Sun Pharmaceutical Industries Inc has filed for 5 different strengths of generic version for Morphine Sulfate. Given below are the details of the strengths of this generic introduced by Sun Pharm Industries.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 200MG | tablet, extended release | Discontinued | ORAL | N/A | Aug 25, 2016 |
| 15MG | tablet, extended release | Discontinued | ORAL | N/A | Aug 25, 2016 |
| 30MG | tablet, extended release | Discontinued | ORAL | N/A | Aug 25, 2016 |
| 100MG | tablet, extended release | Discontinued | ORAL | N/A | Aug 25, 2016 |
| 60MG | tablet, extended release | Discontinued | ORAL | N/A | Aug 25, 2016 |
28. TEVA PHARMS USA
Teva Pharmaceuticals Usa has filed for 8 different strengths of generic version for Morphine Sulfate. Given below are the details of the strengths of this generic introduced by Teva Pharms Usa.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 100MG | capsule, extended release | Discontinued | ORAL | N/A | Dec 29, 2014 |
| 60MG | capsule, extended release | Discontinued | ORAL | N/A | Dec 29, 2014 |
| 50MG | capsule, extended release | Discontinued | ORAL | N/A | Dec 29, 2014 |
| 80MG | capsule, extended release | Discontinued | ORAL | N/A | Dec 29, 2014 |
| 20MG | capsule, extended release | Discontinued | ORAL | N/A | Dec 29, 2014 |
| 30MG | capsule, extended release | Discontinued | ORAL | N/A | Dec 29, 2014 |
| 70MG | capsule, extended release | Discontinued | ORAL | N/A | Jun 3, 2015 |
| 40MG | capsule, extended release | Discontinued | ORAL | N/A | Jun 3, 2015 |
29. TRIS PHARMA INC
Tris Pharma Inc has filed for 3 different strengths of generic version for Morphine Sulfate. Given below are the details of the strengths of this generic introduced by Tris Pharma Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 100MG/5ML | solution | Prescription | ORAL | AA | May 12, 2015 |
| 10MG/5ML | solution | Prescription | ORAL | AA | May 12, 2015 |
| 20MG/5ML | solution | Discontinued | ORAL | N/A | May 18, 2016 |
Manufacturing Plant Locations New
Tris Pharma Inc's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Tris Pharma Inc as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| United States |
| |||
30. UPSHER SMITH LABS
Upsher Smith Laboratories Llc has filed for 8 different strengths of generic version for Morphine Sulfate. Given below are the details of the strengths of this generic introduced by Upsher Smith Labs.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 20MG | capsule, extended release | Prescription | ORAL | N/A | Jun 3, 2013 |
| 10MG | capsule, extended release | Prescription | ORAL | N/A | Jun 3, 2013 |
| 80MG | capsule, extended release | Prescription | ORAL | N/A | Jun 3, 2013 |
| 60MG | capsule, extended release | Prescription | ORAL | N/A | Jun 3, 2013 |
| 50MG | capsule, extended release | Prescription | ORAL | N/A | Jun 3, 2013 |
| 30MG | tablet | Prescription | ORAL | AB | Jul 22, 2019 |
| 100MG
(reference standard) | capsule, extended release | Prescription | ORAL | N/A | Jun 3, 2013 |
| 15MG | tablet | Prescription | ORAL | AB | Jul 22, 2019 |
31. VISTAPHARM
Vistapharm Inc has filed for 2 different strengths of generic version for Morphine Sulfate. Given below are the details of the strengths of this generic introduced by Vistapharm.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 20MG/5ML | solution | Discontinued | ORAL | N/A | Jan 5, 2012 |
| 10MG/5ML | solution | Discontinued | ORAL | N/A | Jan 5, 2012 |
32. WATSON LABS
Watson Laboratories Inc has filed for 3 different strengths of generic version for Morphine Sulfate. Given below are the details of the strengths of this generic introduced by Watson Labs.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1MG/ML | injectable | Discontinued | INJECTION | N/A | Sep 30, 1991 |
| 0.5MG/ML | injectable | Discontinued | INJECTION | N/A | Sep 30, 1991 |
| 100MG | tablet, extended release | Discontinued | ORAL | N/A | Jan 30, 2001 |
33. WINDER LABS LLC
Winder Laboratoiries Llc has filed for 3 different strengths of generic version for Morphine Sulfate. Given below are the details of the strengths of this generic introduced by Winder Labs Llc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 20MG/5ML | solution | Prescription | ORAL | AA | Feb 12, 2021 |
| 10MG/5ML | solution | Prescription | ORAL | AA | Feb 12, 2021 |
| 100MG/5ML | solution | Prescription | ORAL | AA | Feb 12, 2021 |